A study investigating association between HER2 amplification and cetuximab efficacy in patients with metastatic colorectal cancer (mCRC) harbouring extended wild-type RAS
Latest Information Update: 08 Dec 2016
At a glance
- Drugs Cetuximab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 22 Nov 2016 New trial record
- 11 Oct 2016 Results presented at the 41st European Society for Medical Oncology Congress